The co-predictive value of a cardiovascular score for CV outcomes in diabetic patients with no atrial fibrillation.


Journal

Diabetes/metabolism research and reviews
ISSN: 1520-7560
Titre abrégé: Diabetes Metab Res Rev
Pays: England
ID NLM: 100883450

Informations de publication

Date de publication:
07 2019
Historique:
received: 25 11 2018
revised: 30 01 2019
accepted: 18 02 2019
pubmed: 23 2 2019
medline: 8 2 2020
entrez: 22 2 2019
Statut: ppublish

Résumé

Risk factors included in the cardiovascular (CHA We accessed individual data from 610 diabetic patients without AF at baseline included in the prospective cohort of the Malmö Diet and Cancer study. Main outcome measure was the occurrence of cardiovascular events (stroke, coronary events) and death. Mean follow-up was 14.5 ± 5 years (8845 person/years). The CHA In this population-based study on diabetic patients without AF, the CHA

Sections du résumé

BACKGROUND
Risk factors included in the cardiovascular (CHA
METHODS
We accessed individual data from 610 diabetic patients without AF at baseline included in the prospective cohort of the Malmö Diet and Cancer study. Main outcome measure was the occurrence of cardiovascular events (stroke, coronary events) and death. Mean follow-up was 14.5 ± 5 years (8845 person/years).
RESULTS
The CHA
CONCLUSIONS
In this population-based study on diabetic patients without AF, the CHA

Identifiants

pubmed: 30790434
doi: 10.1002/dmrr.3145
doi:

Types de publication

Evaluation Study Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e3145

Informations de copyright

© 2019 John Wiley & Sons, Ltd.

Auteurs

Giuseppe Patti (G)

Cardiology, University of L'Aquila, L'Aquila, Italy.
Campus Bio-Medico Hospital, Rome, Italy.

Alessandro Sticchi (A)

Campus Bio-Medico Hospital, Rome, Italy.

Vincenzo Pasceri (V)

Interventional Cardiology, San Filippo Neri Hospital of Rome, Rome, Italy.

Fabrizio Ricci (F)

Institute of Advanced Biomedical Technologies, Department of Neuroscience, Imaging and Clinical Sciences, "G. d'Annunzio" University, Chieti, Italy.
Department of Clinical Sciences, Malmö, Faculty of Medicine, Lund University, Malmö, Sweden.

Giulia Renda (G)

Institute of Cardiology, Department of Neuroscience, Imaging and Clinical Sciences, and Center of Excellence on Aging, CeSI-Met, G. d'Annunzio University, Chieti, Italy.

Viktor Hamrefors (V)

Department of Clinical Sciences, Malmö, Faculty of Medicine, Lund University, Malmö, Sweden.
Department of Internal Medicine, Skåne University Hospital, Malmö, Sweden.

Olle Melander (O)

Department of Clinical Sciences, Malmö, Faculty of Medicine, Lund University, Malmö, Sweden.
Department of Internal Medicine, Skåne University Hospital, Malmö, Sweden.

Richard Sutton (R)

National Heart and Lung Institute, Imperial College, London, UK.

Gunnar Engström (G)

Department of Clinical Sciences, Malmö, Faculty of Medicine, Lund University, Malmö, Sweden.

Raffaele De Caterina (R)

Cardiology, University of Pisa, Pisa, Italy.

Artur Fedorowski (A)

Department of Clinical Sciences, Malmö, Faculty of Medicine, Lund University, Malmö, Sweden.
Department of Cardiology, Skåne University Hospital, Malmö, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH